Medroxyprogesterone acetate 104mg/0.65mL; SC inj; contains parabens. Medroxyprogesterone acetate inhibits the secretion of gonadotropins which primarily prevents follicular maturation and ovulation ...

FDA Adds Brain Tumor Warning to Depo-Provera Birth Control Shot THURSDAY, Dec. 18, 2025 (HealthDay News — The U.S. Food and Drug Administration (FDA) approved a new safety warning for Depo-Provera, a ...

The FDA has approved a label change on the long-acting injectable contraceptive depot medroxyprogesterone acetate, commonly known as Depo-Provera, to warn users of a potential risk of meningioma. The ...

March 31, 2005 — The U.S. Food and Drug Administration (FDA) has approved a once-monthly formulation of ibandronate sodium for the treatment and prevention of postmenopausal osteoporosis; entecavir ...

The U.S. Food and Drug Administration (FDA) approved a new safety warning for Depo-Provera, a widely used birth control shot made by Pfizer, alerting patients to a possible risk for a type of brain ...

Christy Bieber has a JD from UCLA School of Law and began her career as a college instructor and textbook author. She has been writing full time for over a decade with a focus on making financial and ...